Enantiocomplementary Bioreduction of Flexible Ring N ‐(3‐Oxobutyl)Heterocycles Providing Enantiopure Chiral Fragments for Drug Discovery
ChemBioChem · 2025
DOI: 10.1002/cbic.202500601 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Máté Gergő Honvári und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Mű…. Hauptthemen laut MEDLINE: Heterocyclic Compounds, Drug Discovery. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund (NRDI), European Union,, National Authority for Scientific Research and Innovation (Romania), European Regional Development Fund (NextGenerationEU), RENZI.
Abstract (Originalsprache)
In this study, the bioreduction of prochiral N ‐(3‐oxobutyl)heterocycles comprising various (partially) saturated, flexible rings is explored using microbial whole‐cell ketoreductases such as wild‐type yeast strains including baker's yeast ( Saccharomyces cerevisiae ) and Escherichia coli cells expressing two enantiocomplementary recombinant alcohol dehydrogenases. Initially, four wild‐type yeast strains are screened for ketoreductase activity on a series of nine flexible N‐heterocycles with prochiral carbonyl group in the N ‐(3‐oxobutyl) sidechain. The yeast strains resulted in the corresponding ( S )‐alcohols with a low to moderate conversions. Using recombinant alcohol dehydrogenase whole‐cell preparations as biocatalysts (( S )‐selective ADH from Rhodococcus aetherivorans (RaADH) and ( R )‐selective ADH from Lactobacillus kefir (LkADH)) resulted in higher conversions in most cases, while maintaining the full enantiotopic selectivity. Usually, the preparative‐scale bioreductions showed comparable or even higher conversions than those observed in the small‐scale screening reactions, resulting in virtually enantiopure ( S )‐ and ( R )‐alcohols (ee > 99%), which are promising chiral fragments with a high degree of drug‐likeness. Docking studies confirmed the absolute configuration of the forming ( S )‐ and ( R )‐alcohols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, Budapest, H-1111, Hungary.
- Fermentia Microbiological Ltd, Berlini út 47-49, Budapest, H-1049, Hungary.
- Witaria Ltd, Luther utca 4-6, Budapest, H-1087, Hungary.
- Biocatalysis and Biotransformation Research Centre, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University of Cluj-Napoca, Arany János str. 11., Cluj-Napoca, RO-400028, Romania.
ORCID-Profile: Pál Csuka, Viktória Bódai, László Poppe, Gábor Hornyánszky
Förderung
- Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund (NRDI), European Union,
- National Authority for Scientific Research and Innovation (Romania), European Regional Development Fund (NextGenerationEU), RENZI
Zitieren
APA
Honvári, M. G., Mócza, L. A., Kucsinka, B. A., Csuka, P., Bódai, V., Scrob, D. M., Poppe, L., & Hornyánszky, G. (2025). Enantiocomplementary Bioreduction of Flexible Ring N ‐(3‐Oxobutyl)Heterocycles Providing Enantiopure Chiral Fragments for Drug Discovery. ChemBioChem. https://doi.org/10.1002/cbic.202500601
Vancouver
Honvári MG, Mócza LA, Kucsinka BA, Csuka P, Bódai V, Scrob DM, et al. Enantiocomplementary Bioreduction of Flexible Ring N ‐(3‐Oxobutyl)Heterocycles Providing Enantiopure Chiral Fragments for Drug Discovery. ChemBioChem. 2025. doi:10.1002/cbic.202500601
BibTeX
@article{Honvri2025,
author = {Honvári, Máté Gergő and Mócza, Levente András and Kucsinka, Bence Attila and Csuka, Pál and Bódai, Viktória and Scrob, Diana Maria and Poppe, László and Hornyánszky, Gábor},
title = {Enantiocomplementary Bioreduction of Flexible Ring N ‐(3‐Oxobutyl)Heterocycles Providing Enantiopure Chiral Fragments for Drug Discovery},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500601}
}
EUVIMED